coronavirus vaccine news update: Eleven months after the first case of deadly coronavirus was detected in India, country's drug regulator, Drug Controller General of India (DCGI) on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to millions.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Commenting on the big development of coronavirus vaccines approvals, PM Narendra Modi congratulated India and said that it would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! PM further said that this shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.

Congratulations!

PM Narendra Modi tweeted, "A decisive turning point to strengthen a spirited fight! 

DCGI granting approval to vaccines of @SerumInstIndia and @BharatBiotech accelerates the road to a healthier and COVID-free nation. 

Congratulations India. 

Congratulations to our hardworking scientists and innovators."

Made In India: Aatmanirbhar Bharat

Made in India: Aatmanirbhar Bharat

In another tweet, PM said, "It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion."

Gratitude

Futher, PM Modi said, "We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives."

The vaccine will be first offered to one crore healthcare workers, along with two crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with co-morbidities.